Effectiveness of Moyo Device on Intrapartum Detection of Abnormal Fetal Heart Rate: A Randomized Controlled Trial in Ethiopia

Effectiveness of intermittent fetal heart rate monitoring using Moyo or Pinard fetoscope on Intrapartum Detection of Abnormal Fetal Heart Rate and adverse birth outcomes in general hospitals of Southern Ethiopia: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202305607000259

Enrollment

2518

Registered

2023-05-05

Start date

2022-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Moyo Fetal heart rate monitor

Pinard Fetoscope

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: -Participants with an estimated gestational age of =37 weeks - Participants with =4 cm cervical dilatation at admission

Exclusion criteria

Exclusion criteria: -Participants scheduled for cesarean section (CS) -Participants with multiple pregnancies -Participants with abnormal FHR on admission i.e. absent; FHR160 beats/minutes (BPM)or undetectable -Participants with common pregnancy complications -Participants with precipitous delivery -Participants with =9 cm cervical dilatation at admission.

Design outcomes

Primary

Measure	Time frame
The primary outcome measure was abnormal FHR defined as normal (110 to 160 beats/min (bpm) throughout labor and delivery) or abnormal (absent, 160 beats/min). It was measured at ‘0’, ‘5th’, and 10th minutes of the initial contact with the study participant. The measurement of FHR continued till the woman delivered at an interval of every 30 minutes in the first stage of labor and every 15 minutes during the second stage of labor. The start of FHR auscultation within the first 10 minutes following the uterine quiescence. The report or documentation for the control arm was on the prepared follow-up sheet, where the count would be rounded to the nearest 5 beats per minute increment. Abnormal FHR is reached after at least one confirmed measurement at any point during labor.	—

Measure

Time frame

The primary outcome measure was abnormal FHR defined as normal (110 to 160 beats/min (bpm) throughout labor and delivery) or abnormal (absent, 160 beats/min). It was measured at ‘0’, ‘5th’, and 10th minutes of the initial contact with the study participant. The measurement of FHR continued till the woman delivered at an interval of every 30 minutes in the first stage of labor and every 15 minutes during the second stage of labor. The start of FHR auscultation within the first 10 minutes following the uterine quiescence. The report or documentation for the control arm was on the prepared follow-up sheet, where the count would be rounded to the nearest 5 beats per minute increment. Abnormal FHR is reached after at least one confirmed measurement at any point during labor.

—

Secondary

Measure	Time frame
Secondary outcomes included the Apgar score at first and fifth minutes (abnormal is defined as an Apgar score <7); mode of delivery (Spontaneous vaginal delivery, operative delivery: CS and instrumental delivery); perinatal outcome at birth (i.e., normal, admission to the neonatal unit, or FSB), the outcome at 24-h (i.e., normal, still admitted to the neonatal unit). Obstetric time intervals included: admission to abnormal FHR detection, admission to delivery, from abnormal FHR detection to delivery.	—

Measure

Time frame

Secondary outcomes included the Apgar score at first and fifth minutes (abnormal is defined as an Apgar score <7); mode of delivery (Spontaneous vaginal delivery, operative delivery: CS and instrumental delivery); perinatal outcome at birth (i.e., normal, admission to the neonatal unit, or FSB), the outcome at 24-h (i.e., normal, still admitted to the neonatal unit). Obstetric time intervals included: admission to abnormal FHR detection, admission to delivery, from abnormal FHR detection to delivery.

—

Countries

Ethiopia

Contacts

Public ContactTamiru Shibiru

Associate professor in Internal medicine at Arba Minch University

drtamshib1@gmail.com0911704767

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026